N-(3-chloro-4-fluorophenyl)-5-[5-(1-methylpyrazol-4-yl)thiophen-2-yl]-1-oxo-1,2,6-thiadiazinane-3-carboxamide
C18H17ClFN5O2S2 — CID 156570390
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-chloro-4-fluorophenyl)-5-[5-(1-methylpyrazol-4-yl)thiophen-2-yl]-1-oxo-1,2,6-thiadiazinane-3-carboxamide
N-(3-chloro-4-fluorophenyl)-5-[5-(1-methylpyrazol-4-yl)thiophen-2-yl]-1-oxo-1,2,6-thiadiazinane-3-carboxamide (PubChem CID 156570390) has the molecular formula C18H17ClFN5O2S2 and a molecular weight of 453.95 g/mol. Its IUPAC name is N-(3-chloro-4-fluorophenyl)-5-[5-(1-methylpyrazol-4-yl)thiophen-2-yl]-1-oxo-1,2,6-thiadiazinane-3-carboxamide.
Molecular Properties
| Compound Name | N-(3-chloro-4-fluorophenyl)-5-[5-(1-methylpyrazol-4-yl)thiophen-2-yl]-1-oxo-1,2,6-thiadiazinane-3-carboxamide |
|---|---|
| PubChem CID | 156570390 |
| Molecular Formula | C18H17ClFN5O2S2 |
| Molecular Weight | 453.95 g/mol |
| Exact Mass | 453.05 |
| IUPAC Name | N-(3-chloro-4-fluorophenyl)-5-[5-(1-methylpyrazol-4-yl)thiophen-2-yl]-1-oxo-1,2,6-thiadiazinane-3-carboxamide |
| SMILES | Cn1cc(-c2ccc(C3CC(C(=O)Nc4ccc(F)c(Cl)c4)NS(=O)N3)s2)cn1 |
| InChI | InChI=1S/C18H17ClFN5O2S2/c1-25-9-10(8-21-25)16-4-5-17(28-16)14-7-15(24-29(27)23-14)18(26)22-11-2-3-13(20)12(19)6-11/h2-6,8-9,14-15,23-24H,7H2,1H3,(H,22,26) |
| InChIKey | SYXKDLGRNLGQKZ-UHFFFAOYSA-N |
| XLogP | 3.15 |
| TPSA | 88.05 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.95 |
| LogP ≤ 5 | 3.15 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156570390 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.